Cargando…

Editorial: Novel Drugs Targeting the Microenvironment and the Epigenetic Changes in Hematopoietic Malignancies

Detalles Bibliográficos
Autores principales:	Gulei, Diana, Tomuleasa, Ciprian, Qian, Liren, Bagacean, Cristina, Croce, Carlo M., Ghiaur, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849152/ https://www.ncbi.nlm.nih.gov/pubmed/33536922 http://dx.doi.org/10.3389/fphar.2020.614614

Ejemplares similares

Targeting the Microenvironment in MDS: The Final Frontier
por: Teodorescu, Patric, et al.
Publicado: (2020)

Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
por: Munteanu, Raluca, et al.
Publicado: (2023)

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023)

The Malignant Role of Exosomes as Nanocarriers of Rare RNA Species
por: Zimta, Alina-Andreea, et al.
Publicado: (2020)

Coagulopathy in Acute Promyelocytic Leukemia: Can We Go Beyond Supportive Care?
por: Hambley, Bryan C., et al.
Publicado: (2021)

Characterization of extrachromosomal circular DNA in patients with acute myeloid leukemia: proof-of-concept report using cohorts from Beijing and Shanghai
por: Qian, Liren, et al.
Publicado: (2022)

Editorial: Modern Approaches to Hemophilia Management: Gene Therapy and Beyond
por: Coriu, Daniel, et al.
Publicado: (2022)

Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?
por: Tomuleasa, Ciprian, et al.
Publicado: (2013)

Editorial: Anti-cancer effects of botanical drugs targeting the tumor microenvironment
por: Cheng, Chien-shan, et al.
Publicado: (2023)

Editorial: Natural Product Epigenetic Modulators and Inhibitors
por: Ntie-Kang, Fidele, et al.
Publicado: (2021)

Editorial: Epigenetic regulation and therapy resistance in cancer
por: Zhu, Yongxia, et al.
Publicado: (2023)

Medical Application of Hydrogen in Hematological Diseases
por: Qian, Liren, et al.
Publicado: (2019)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

Regulation of drug metabolizing enzymes in the leukaemic bone marrow microenvironment
por: Su, Meng, et al.
Publicado: (2019)

Editorial: Biological drugs and biosimilars in autoimmune diseases
por: Wajda, Anna, et al.
Publicado: (2023)

MicroRNAs Associated With a Good Prognosis of Acute Myeloid Leukemia and Their Effect on Macrophage Polarization
por: Neaga, Alexandra, et al.
Publicado: (2021)

Editorial: New Approaches to Tackle EMT and Fibrosis: From Epigenetics to Nanotechnology
por: Battistelli, Cecilia, et al.
Publicado: (2021)

Editorial: Environmental Enrichment as a Treatment? Epigenetic Mechanisms, Challenges and Limitations
por: Redolat, Rosa, et al.
Publicado: (2021)

Editorial: Natural compounds regulating epigenetics for treating chronic inflammatory diseases
por: Zhang, Mingyu, et al.
Publicado: (2023)

An intravenous anesthetic drug-propofol, influences the biological characteristics of malignant tumors and reshapes the tumor microenvironment: A narrative literature review
por: Zhou, Xueliang, et al.
Publicado: (2022)

Editorial: The role of hematopoietic and immune microenvironment in hematopoietic stem cell transplantation
por: Wang, Xiaoqi, et al.
Publicado: (2023)

Editorial: Drug-drug interactions in pharmacology
por: Pichini, Simona, et al.
Publicado: (2023)

Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy
por: Iluta, Sabina, et al.
Publicado: (2021)

Editorial: Epigenetic mechanisms and post-translational modifications as novel therapeutic targets in cancer
por: Shi, Zhi, et al.
Publicado: (2022)

Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
por: Jaafari, Abdeslam, et al.
Publicado: (2022)

Galloflavin Relieves the Malignant Behavior of Colorectal Cancer Cells in the Inflammatory Tumor Microenvironment
por: Guo, Li, et al.
Publicado: (2021)

Editorial: Local and traditional medicine in regulation of the cancer immune suppression microenvironment, Volume II
por: Hong, Shicui, et al.
Publicado: (2023)

Editorial: Rising Stars in Hematologic Malignancies 2021
por: Qian, Liren, et al.
Publicado: (2022)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Editorial: Advances in Drug Formulation
por: Mukherjee, Biswajit, et al.
Publicado: (2020)

Editorial: New immunotherapeutic and pharmacological targets and strategies in haematological malignancies
por: Williams, Mark Thomas Shaw, et al.
Publicado: (2023)

Editorial: Phytochemicals targeting autophagy in treatment of bacterial infection and malignancies
por: Bai, Xiaoxue, et al.
Publicado: (2023)

Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
por: Tigu, Adrian Bogdan, et al.
Publicado: (2023)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

Editorial: Metalloenzymes: Potential Drug Targets
por: Iqbal, Jamshed, et al.
Publicado: (2021)

Editorial: Advances in drug-induced diseases
por: Liu, Yao, et al.
Publicado: (2023)

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
por: Kim, Seong Keun, et al.
Publicado: (2022)

Extramedullary Hematopoiesis of the Liver and Spleen
por: Cenariu, Diana, et al.
Publicado: (2021)

Hematopoietic Stem Cell Transplantation in Acute Promyelocytic Leukemia in the Era of All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO)
por: Colita, Andrei, et al.
Publicado: (2023)

Progress in Hematopoietic Stem Cell Transplantation and Cellular Therapies
por: Cenariu, Diana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_741pj5v6b046kqqd9541037src